Transplant Genomics developing blood test to improve kidney transplant outcomes
Transplant Genomics Inc.'s TruGraf blood test could detect problems with kidney transplants earlier than the current methods, and help doctors fine-tune a transplant recipient's immunosuppressive regimen to delay or prevent transplant rejection.
About half of the 17,000 kidney transplants done annually in the U.S. fail within 10 years. For this reason, kidney transplants are routinely monitored for creatinine, a measure of kidney function.
But creatinine is an insensitive, lagging indicator. It does not rise until there is a